Abstract
Strategies for gene delivery into neurons, either to study the molecular biology of brain function or for gene therapy, must utilize vectors that persist stably in postmitotic cells and that can be targeted both spatially and temporally in the nervous system in vivo. Herpes simplex virus type 1 (HSV-1) possesses multiple features that make it an ideal vector for genetic intervention in the nervous system. In particular, it accepts large molecules of exogenous DNA; it infects nondividing cells from a wide range of hosts with high efficiency; it enables the strong expression of foreign genes; it is episomal and thereby does not cause integration effects; its infection of postmitotic cells is stable; and its particles can be concentrated to relatively high titers. Here, we describe the considerations involved in the preparation and use of a herpes simplex virus type 1 (HSV-1) amplicon as a vector for gene transfer into neurons both in vitro and in vivo.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Spaete R, Frenkel N (1982) The herpes simplex virus amplicon: a new eukaryotic defective-virus cloning-amplifying vector. Cell 30:305–310
Roizman B, Jenkins FJ (1985) Genetic engineering of novel genomes of large DNA viruses. Science 229:1208–1214
Stow N, McMonagle E (1982) Propagation of foreign DNA sequences linked to a herpes simplex virus origin of replication. In: Gluzman Y (ed) Eucaryotic viral vectors. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 199–204
Spaete R, Frenkel N (1985) The herpes simplex virus amplicon: analyses of cis-acting replication functions. Proc Natl Acad Sci U S A 82:694–698
Vlazny D, Kwong A, Frenkel N (1982) Site-specific cleavage/packaging of herpes simplex virus DNA and the selective maturation of nucleocapsids containing full-length viral DNA. Proc Natl Acad Sci U S A 79:1423–1427
Fraefel C et al (1996) Helper virus-free transfer of herpes simplex virus type I plasmid vectors into neural cells. J Virol 68:7190–7187
Fenno L et al (2014) Targeting cells with single vectors using multiple-feature Boolean logic. Nat Methods 11:763–782
Yonehara K et al (2013) The first stage of cardinal direction selectivity is localized to the dendrites of retinal ganglion cells. Neuron 79:1078–1085
Satou et al (2022) A viral toolbox for conditional and transneuronal gene expression in zebrafish. eLife 2022 Jul 22;e77153. https://doi.org/10.7554/eLife.77153
Smith IL, Hardwicke MA, Sandri-Goldin RM (1992) Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology 186:74–86
McCarthy AM, McMahan L, Schaffer PA (1989) Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J Virol 63:18–27
Carlezon Jr WA et al (1997) Sensitization to morphine induced by viral-mediated gene transfer. Science 277:812–814
Neve RL (1997) Introduction of glutamate receptor subunit 1 into motor neurons in vivo using a recombinant herpes simplex virus alters the functional properties of AMPA receptors. Neuroscience 79:435–447
Bursztajn S et al (1998) Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer disease mutant does not enhance apoptosis. J Neurosci 18:9790–9799
Lim F et al (1996) Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. BioTechniques 20:460–470
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply
About this protocol
Cite this protocol
Neve, R. (2023). Generation of High-Titer Defective HSV-1 Amplicon Vectors. In: Eldridge, M.A., Galvan, A. (eds) Vectorology for Optogenetics and Chemogenetics. Neuromethods, vol 195. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2918-5_3
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2918-5_3
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2917-8
Online ISBN: 978-1-0716-2918-5
eBook Packages: Springer Protocols